Area of research
Nutrition and Dietetics · Cancer Research
Research interest
Research focused on Human leukocyte antigen and Clopidogrel, with related work in Transcription factor, Zearalenone, Downregulation and upregulation. Notable publications include 'HLA class II allele DRB1*16:02 is associated with anti-NMDAR encephalitis', 'Influence of Genetic Polymorphisms on Clopidogrel Response and Clinical Outcomes in Patients with Acute Ischemic Stroke CYP2C19 Genotype on Clopidogrel Response', and 'Nrf2: A promising therapeutic target in bone-related diseases'.
Memantine for Premature Atrial Contractions: A Phase 2 Randomized Clinical Trial
Retrospective study of the impact of diabetes on the severity and prognosis of COVID‑19
Downregulated Expression and Hypermethylation of SIRT1 in Patients with Kashin-Beck Disease–Mediated Chondrocyte Apoptosis May Potentially Be Ameliorated by Selenium Supplement
A nomogram model for predicting advanced liver fibrosis in patients with hepatitis B: A multicenter study
Nrf2: A promising therapeutic target in bone-related diseases
HLA class II allele<i>DRB1*16:02</i>is associated with anti-NMDAR encephalitis
GP73, a novel TGF-β target gene, provides selective regulation on Smad and non-Smad signaling pathways
Influence of Genetic Polymorphisms on Clopidogrel Response and Clinical Outcomes in Patients with Acute Ischemic Stroke CYP2C19 Genotype on Clopidogrel Response
Analysis of zearalenone and <i>α</i>‐zearalenol in 100 foods and medicinal plants determined by <scp>HPLC‐FLD</scp> and positive confirmation by <scp>LC‐MS‐MS</scp>